Presence of N-glycosylated transthyretin in plasma of V30M carriers in familial amyloidotic polyneuropathy: An escape from ERAD

Journal of Cellular and Molecular Medicine

Volumn 17, Issue 3, 2013, Pages 429-435

  Teixeira, Anabela C ^a   Saraiva, Maria J ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

ERAD; N glycosylation; Transthyretin

Indexed keywords

GLYCOPEPTIDASE; MONOCLONAL ANTIBODY; PREALBUMIN;

ANIMAL; ARTICLE; BLOOD; CEREBROSPINAL FLUID; ENDOPLASMIC RETICULUM ASSOCIATED DEGRADATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILIAL AMYLOID POLYNEUROPATHY; GENETICS; GLYCOSYLATION; HETEROZYGOTE; HUMAN; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INTESTINE; KIDNEY; LIVER; LIVER TRANSPLANTATION; MASS SPECTROMETRY; METABOLISM; MOUSE; MUTATION; PATHOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE;

AMYLOID NEUROPATHIES, FAMILIAL; ANIMALS; ANTIBODIES, MONOCLONAL; ENDOPLASMIC RETICULUM-ASSOCIATED DEGRADATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOSYLATION; HETEROZYGOTE; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INTESTINES; KIDNEY; LIVER; LIVER TRANSPLANTATION; MASS SPECTROMETRY; MICE; MICE, TRANSGENIC; MUTATION; PEPTIDE-N4-(N-ACETYL-BETA-GLUCOSAMINYL) ASPARAGINE AMIDASE; PREALBUMIN; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

MUS MUSCULUS;

EID: 84875784710     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12024     Document Type: Article

References (19)

1. Saraiva MJ, Magalhães J, Ferreira N, et al. Transthyretin deposition in familial amyloidotic polyneuropathy. Curr Med Chem. 2012; 19: 2304-11.
2. Saraiva MJM, Costa PP, Goodman DS. Studies on plasma transthyretin (prealbumin) in familial amyloidotic polyneuropathy, Portuguese type. J Lab Clin Med. 1983; 102: 590-603.
3. Sebastião MP, Saraiva MJ, Damas AM. The crystal structure of amyloidogenic Leu55 -> Pro transthyretin variant reveals a possible pathway for transthyretin polymerization into amyloid fibrils. J Biol Chem. 1998; 273: 24715-22.
4. Redondo C, Damas AM, Olofsson A, et al. Search for intermediate structures in transthyretin fibrillogenesis: soluble tetrameric Tyr78Phe TTR expresses a specific epitope present only in amyloid fibrils. J Mol Biol. 2000; 304: 461-70.
5. Magy N, Liepnieks JJ, Gil H, et al. A transthyretin mutation (Tyr78Phe) associated with peripheral neuropathy, carpal tunnel syndrome and skin amyloidosis. Amyloid. 2003; 10: 29-33.
6. Goldsteins G, Persson H, Andersson K, et al. Exposure of cryptic epitopes on transthyretin only in amyloid and in amyloidogenic mutants, Proc. Natl. Acad. Sci. USA. 1999; 96: 3108-13.
7. Palha JA, Moreira P, Olofsson A, et al. Antibody recognition of amyloidogenic transthyretin variants in serum of patients with familial amyloidotic polyneuropathy. J Mol Med. 2001; 78: 703-7.
8. Kohno K, Palha JA, Miyakawa K, et al. Analysis of amyloid deposition in a transgenic mouse model of homozygous familial amyloidotic polyneuropathy. Am J Pathol. 1997; 150: 1497-508.
9. Episkopou V, Maeda S, Nishiguchi S, et al. Disruption of the transthyretin gene results in mice with depressed levels of plasma retinol and thyroid hormone. Proc Natl Acad Sci USA. 1993; 90: 2375-9.
10. Almeida MR, Damas AM, Lans MC, et al. Thyroxine binding to transthyretin Met 119 - comparative studies of different heterozygotic carriers and structural analysis. Endocrine. 1997; 6: 309-15.
11. Kaplan B, German G, Ravid M, et al. Determination of amyloid type by ELISA using milligram amounts of tissue. Clin Chim Acta. 1994; 229: 171-9.
12. Sousa MM, Saraiva MJ. Internalization of transthyretin: evidence for a novel yet unidentified receptor-associated protein (RAP) - sensitive receptor. J Biol Chem. 2001; 276: 14420-5.
13. Yamashita T, Ando Y, Suhr O, et al. A new diagnostic procedure to detect unknown transthyretin (TTR) mutations in familial amyloidotic polyneuropathy (FAP). J Neurol Sci. 2000; 173: 154-9.
14. Alves IL, Hays MT, Saraiva MJM. Comparative stability and clearance of Met30 transthyretin and Met119 transthyretin. Eur J Biochem. 1997; 249: 662-8.
15. Sekijima Y, Wiseman RL, Matteson J, et al. The biological and chemical basis for tissue-selective amyloid disease. Cell. 2005; 121: 73-85.
16. Hammond C, Braakman I, Helenius A. Role of N-linked oligosaccharide recognition, glucose trimming, and calnexin in glycoprotein folding and quality control. Proc Natl Acad Sci USA. 1994; 91: 913-7.
17. Bolt G, Kristensen C, Steenstrup TD. Posttranslational N-glycosylation takes place during the normal processing of human coagulation factor VII. Glycobiology. 2005; 15: 541-7.
18. Ruiz-Canada C, Kelleher DJ, Gilmore R. Cotranslational and posttranslational N-glycosylation of polypeptides by distinct mammalian OST isoforms. Cell. 2009; 136: 272-83.
19. Sato T, Sako Y, Sho M, et al. STT3B-dependent posttranslational N-glycosylation as a surveillance system for secretory protein. Mol Cell. 2012; 47: 99-110.